Cure My Disease

Don't miss your cure!

 Log in / Sign up

A tablet app could help rural clinics catch skin diseases without a dermatologist

NCT ID NCT06292260

Diagnosis Sponsor: Tulane University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 13, 2026 · Last updated Oct 14, 2026 · Updated 1 time

Summary

Researchers are testing eSkinHealth, a tablet app that works as a portable patient chart for skin conditions and supports remote dermatology when internet access is poor. The study enrolls about 1,000 healthcare providers in Cote d'Ivoire, including doctors, nurses, and community health workers. The team compares how many skin diseases, including neglected tropical diseases, get diagnosed and followed up in rural and urban clinics that use the app versus those that do not.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
eSkinHealth, a tablet app for skin disease tracking and remote dermatology
What this could lead to
If the app helps health workers find and track more skin conditions, it could become a low-cost tool for catching neglected tropical diseases earlier in places with few dermatologists.
What could go wrong
The study measures case detection and follow-up, not whether patients get better. A tablet tool may not work as well in busy clinics, and results from Cote d'Ivoire may not carry over to other countries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,000 people

The number who actually took part.

Started

Mar 2024

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

1. Healthcare providers (i.e., doctors, nurses, or community health workers/volunteers) Inclusion Criteria: * 18 years or older * Working at primary health centers or clinics in Cote d'Ivoire * Able to read and speak fluent French * Willing to participate in the pilot study for the 12-month study duration * Willing to use a provided tablet with the eSkinHealth app if they were assigned to the intervention group * Able to consent for oneself Exclusion Criteria: * Planning to leave their job at the clinics within the study period * Difficulty operating mobile devices 2. Patients with skin diseases Inclusion Criteria: * Clinically suspected or diagnosed with skin NTDs (Buruli ulcer, leprosy, and yaws) or have other clinically diagnosed skin conditions * Able to consent for oneself Exclusion Criteria: * Clinically diagnosed skin conditions outside of the target site

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Buruli ulcer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Buruli ulcer disease filarial elephantiasis leprosy mycetoma Neglected Diseases scabies skin disorder yaws

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Skin diseases

Contacts and locations

Locations

  • Hope Commission International

    Abidjan, Côte d’Ivoire

More trials for these conditions

Other studies related to the condition(s) this trial covers.